Star Equity Holdings, Inc. (NASDAQ:STRR – Free Report) – Equities research analysts at Litchfield Hills Research dropped their Q2 2024 earnings per share estimates for Star Equity in a research note issued on Monday, March 25th. Litchfield Hills Research analyst T. O’neill now forecasts that the company will post earnings of ($0.07) per share for […]
Towards the end of 2023 there was a significant increase in M&A activity in the Australian sharemarket. In IML’s small and mid-cap funds an incredible nine of our holdings received takeover offers in this period, including A2B (ASX: A2B), InvoCare (ASX: IVC), Probiotec (ASX: PBP), Symbo and Adbri (ASX: ABC)..
Singapore enhances screening for breast cancer with AI theindependent.sg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theindependent.sg Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in its named patient program.